NCT04600219View on ClinicalTrials.gov

The Effect of Tyrosine Kinase Receptor Axl on Dialysis Prognosis in Chronic Hemodialysis Patients

UnknownOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

December 1, 2021

Study Completion Date

December 1, 2021

Conditions
Hemodialysis Complication
Trial Locations (1)

200272

Department of Nephrology & Rheumatology, Shanghai Tenth People's Hospital, Shanghai

Sponsors

Lead Sponsor

Ai Peng
All Listed Sponsors
lead

Ai Peng

OTHER

NCT04600219 - The Effect of Tyrosine Kinase Receptor Axl on Dialysis Prognosis in Chronic Hemodialysis Patients | Biotech Hunter | Biotech Hunter